The 35 references in paper G. Neklyudova V., S. Avdeev N., G. Baymakanova E., Г. Неклюдова В., С. Авдеев Н., Г. Баймаканова Е. (2014) “Хроническая обструктивная болезнь легких и легочная гипертензия: мозговой натрийуретический пептид как маркер легочной гипертензии // Chronic obstructive pulmonary disease and pulmonary hypertension: brain natriuretic peptide as a marker of pulmonary hypertension” / spz:neicon:pulmonology:y:2013:i:3:p:31-35

1
Kessler R., Faller M., Fourgaut G. et al.Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 159 (1): 158–164.
(check this in PDF content)
2
Авдеев С.Н.Легочная гипертензия при хронических респираторных заболеваниях. В кн.: Чучалин А.Г. (ред.). Пульмонология. Национальное руководство. М.: ГЭОТАР-Медиа; 2009. 599–619.
(check this in PDF content)
3
Авдеев С.Н.Вторичная легочная гипертензия. В кн.: Беленкова Ю.Н., Оганова З.Г. (ред.). Кардиология: Национальное руководство. Краткое издание. М.: ГЭОТАР-Медиа; 2012. 761–766.
(check this in PDF content)
4
Weitzenblum E., Hirth C., Ducolone A. et al. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 1981; 36: 752–758.
(check this in PDF content)
5
Bishop J.E.Hypoxia and pulmonary hypertension in chronic bronchitis. Prog. Respir. Res.1975; 9: 10–16.
(check this in PDF content)
6
Semmens M., Reid L. Pulmonary arterial muscularity and right ventricular hypertrophy in chronic bronchitis and emphysema. Br. J. Dis. Chest 1974; 68: 253–263.
(check this in PDF content)
7
MacNee W. State of the art: Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease (Part 1). Am. J. Respir. Crit. Care Med. 1994; 150: 833–852.
(check this in PDF content)
8
MacNee W.State of the art: Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease (Part 2). Am. J. Respir. Crit. Care Med. 1994; 150: 1158–1168.
(check this in PDF content)
9
Попова К.А., Авдеев С.Н.Значение натрийуретических пептидов в диагностике сердечной недостаточности и других заболеваний. Пульмонология 2006; 4: 106–111.
(check this in PDF content)
10
Национальные рекомендации ВНОК И ОССН по диагностике и лечению ХСН (3-й пересмотр). Сердеч. недостаточность 2010; 11 [1 (57)]: 3–62.
(check this in PDF content)
11
Global Strategy for Diagnosis, Management, and Prevention of COPD (updated 2010).www.goldcopd.org
(check this in PDF content)
12
Galie N., Torbicki A., Barst R. et al.Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the European Society of Cardiology. Eur. Heart J. 2004; 25: 2243–2278.
(check this in PDF content)
13
Quanjer Ph.H., Tammeling G., Cotes J.E. et al.Lung volumes and forced ventilatory flows. Eur. Respir. J. 1993; 6 (Suppl. 16): 5–40.
(check this in PDF content)
14
Berger M., Haimovitz A., Van Tosh A. et al.Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J. Am. Coll. Cardiol. 1985; 6: 359–365.
(check this in PDF content)
15
Kircher B., Himelman R.B., Schiller M.B.Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am. J. Cardiol. 1990; 66 (4): 493–496.
(check this in PDF content)
16
Chaouat A., Begnet A.S., Kadaoui N. et al.Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2005; 172: 189–194.
(check this in PDF content)
17
Scharf S.M., Iqbal M., Keller C. et al. Hemodynamic characterization of patients with severe emphysema. Am. J. Respir. Crit. Care Med. 2002; 166: 314–322.
(check this in PDF content)
18
Vizza C.D., Lynch J.P., Ochoa L.L. et al. Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest 1998; 113: 576–583.
(check this in PDF content)
19
Thabut G., Dauriat G., Stern J.B. et al.Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 2005; 127: 1531–1536.
(check this in PDF content)
20
Yap L.B., Mukerjee D., Timms P.M. et al.Natriuretic peptides, respiratory disease, and the right heart. Chest 2004; 126: 1330–1336.
(check this in PDF content)
21
Mueller C., Scholer A., Laule,Kilian K. et al. The use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N. Engl. J. Med. 2004; 350: 647–654.
(check this in PDF content)
22
Cargill R.I., Lipworth B.J.Acute effects of ANP and BNP on hypoxic pulmonary vasoconstriction in humans. Br. J. Clin. Pharmacol. 1995; 40: 585–590.
(check this in PDF content)
23
Lemos J.A., McGuire D.K., Drazner M.H.B-type natriuretic peptide in cardiovascular disease. Lancet 2003; 362: 316–322.
(check this in PDF content)
24
Klinger J.R., Houtchens J.E., Thaker S. et al.Acute cardiopulmonary hemodynamic effects of brain natriuretic peptidein patients with pulmonary arterial hypertension. Chest 2005; 128 (6, Suppl.): 618S–619S.
(check this in PDF content)
25
Lang C.C., Coutie W.J., Struthers A.D. et al.Elevated levels of brain natriuretic peptide in acute hypoxaemic chronic pulmonary disease. Clin. Sci. (Lond.) 1992; 83: 529–533.
(check this in PDF content)
26
Fujii T., Otsuka T., Tanaca S. et al.Plasma endothelin-1 level in chronic obstructive pulmonary disease: relationship with natriuretic peptide. Respiration 1999; 66: 212–219.
(check this in PDF content)
27
Cabanes L., Richand,Thiriez B., Fulla Y. et al. Brain natriuretic peptide blood levels in the differential diagnosis of dyspnea. Chest 2001; 120: 2047–2050.
(check this in PDF content)
28
Morrison L.K., Harrison A., Krishmaswamy P.I. et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnoea. J. Am. Coll. Cardiol. 2002; 39: 202–205.
(check this in PDF content)
29
Tulevski I., Groenink M., Evan der Well E. et al. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction. Heart 2001; 86: 27–30.
(check this in PDF content)
30
Gerbes A.L, Dagnino L., Nguyen T., Nemer M. Transcription of brain natriuretic peptide genes in human tissues. J. Clin. Endocrinol. Metab. 1994; 78: 1307–1311.
(check this in PDF content)
31
Maisel A.S., Krishnaswamy P., Nowak R.M. et al.Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N. Engl. J. Med. 2002; 347: 161–167.
(check this in PDF content)
32
Bando M., Ishii Y., Sugiyama Y. et al. Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonary. Respir. Med. 1999; 93: 507–514.
(check this in PDF content)
33
Bozkanat E., Tozkoparan E., Baysan O. et al. The significance of elevated brain natriuretic peptide levels in chronic obstructive pulmonary disease. J. Int. Med. Res. 2005; 33 (5): 537–544.
(check this in PDF content)
34
Stolz D., Breidthardt T., Christ,Crain M. et al. Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD. Chest 2008; 133 (5): 1088–1094.
(check this in PDF content)
35
Tanaka T., Kanda T., Takahashi T. et al.Interleukin-6induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes. J. Int. Med. Res. 2004; 32 (1): 57–61. Информация об авторах
(check this in PDF content)